Cargando…

The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis

Detalles Bibliográficos
Autores principales:	Cheon, Jae Hee, Paridaens, Kristine, Awadhi, Sameer Al, Begun, Jakob, Fullarton, John R, Louis, Edouard, Magro, Fernando, Marquez, Juan Ricardo, Moschen, Alexander R, Narula, Neeraj, Rydzewska, Grazyna, Dignass, Axel U, Travis, Simon PL
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2023
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911271/ https://www.ncbi.nlm.nih.gov/pubmed/35421913 http://dx.doi.org/10.5217/ir.2022.00006

Ejemplares similares

Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
por: Louis, Edouard, et al.
Publicado: (2022)

Efficacy of oral prolonged‐release mesalazine in moderately active ulcerative colitis
por: Paridaens, Kristine, et al.
Publicado: (2023)

International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients
por: Caron, Bénédicte, et al.
Publicado: (2023)

iSTART-II: An Update on the i Support Therapy–Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis
por: D’Amico, Ferdinando, et al.
Publicado: (2023)

Assessment of the effectiveness of Budesonide MMX(®) for active, mild-to-moderate ulcerative colitis in the Polish sub-group of the CORE Practice prospective multi-centre observational study
por: Jesionowski, Maciej, et al.
Publicado: (2023)

Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey
por: Schreiber, Stefan, et al.
Publicado: (2012)

Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review
por: Caron, Bénédicte, et al.
Publicado: (2022)

The efficacy and safety of the biosimilar product (Inflectra(®)) compared to the reference drug (Remicade(®)) in rescue therapy in adult patients with ulcerative colitis
por: Kaniewska, Magdalena, et al.
Publicado: (2017)

Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions
por: Dubinsky, Marla, et al.
Publicado: (2023)

Use of granulocyte/monocytapheresis in ulcerative colitis: A practical review from a European perspective
por: Domènech, Eugeni, et al.
Publicado: (2021)

Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis
por: Solitano, Virginia, et al.
Publicado: (2020)

Working Group Guidelines on the nursing roles in caring for patients with Crohn's disease and ulcerative colitis in Poland
por: Golik, Magdalena, et al.
Publicado: (2014)

Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta‐analysis
por: Magro, Fernando, et al.
Publicado: (2021)

Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study
por: Danese, Silvio, et al.
Publicado: (2016)

Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation
por: Cooney, Rachel M, et al.
Publicado: (2007)

Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus
por: D’Amico, Ferdinando, et al.
Publicado: (2023)

The position statement of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic
por: Łodyga, Michał, et al.
Publicado: (2020)

Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries
por: Armuzzi, Alessandro, et al.
Publicado: (2023)

Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
por: Eder, Piotr, et al.
Publicado: (2023)

Eine chirurgisch relevante Zusammenfassung des Addendums zu den DGVS-S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Therapie chronisch entzündlicher Darmerkrankungen in der COVID-19-Pandemie
por: Grunert, Philip C., et al.
Publicado: (2020)

The use of 5-aminosalicylates in Crohn’s disease: a retrospective study using the UK Clinical Practice Research Datalink
por: Hart, Ailsa, et al.
Publicado: (2020)

Solving the questions regarding 5-aminosalitylate formulation in the treatment of ulcerative colitis
por: Naganuma, Makoto
Publicado: (2020)

IBD2020 global forum: results of an international patient survey on quality of care
por: Irving, Peter, et al.
Publicado: (2018)

Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus
por: Awadhi, Sameer Al, et al.
Publicado: (2023)

Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis
por: D’Amico, Ferdinando, et al.
Publicado: (2021)

Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing Effectiveness
por: Zezos, Petros, et al.
Publicado: (2020)

Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results
por: Dignass, Axel, et al.
Publicado: (2016)

Expression of CD49f defines subsets of human regulatory T cells with divergent transcriptional landscape and function that correlate with ulcerative colitis disease activity
por: Weerakoon, Harshi, et al.
Publicado: (2021)

Reporting of endoscopy and histology of ulcerative colitis in routine clinical practice: How far we are!
por: Magro, Fernando, et al.
Publicado: (2023)

Socio-demographic characteristics of patients with diagnosed functional dyspepsia
por: Piotrowicz, Grażyna, et al.
Publicado: (2013)

Quality of life in patients with ulcerative colitis treated surgically
por: Kozłowska, Katarzyna A., et al.
Publicado: (2014)

Management of iron deficiency anemia in inflammatory bowel disease – a practical approach
por: Stein, Jürgen, et al.
Publicado: (2013)

Join the myUEG community and become an official myUEG Associate for free
por: Dignass, Axel, et al.
Publicado: (2021)

Immature granulocytes predict severe acute pancreatitis independently of systemic inflammatory response syndrome
por: Lipiński, Michał, et al.
Publicado: (2017)

The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study
por: Moniuszko, Andrzej, et al.
Publicado: (2017)

Acute pancreatitis and the weekend effect: does weekend admission affect patient outcome?
por: Lipiński, Michał, et al.
Publicado: (2020)

Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis
por: Atreya, Raja, et al.
Publicado: (2016)

Tofacitinib in the treatment of ulcerative colitis: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)
por: Kutschera, Maximilian, et al.
Publicado: (2022)

Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford
por: Pulusu, Samba Siva Reddy, et al.
Publicado: (2020)

Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach
por: Danese, Silvio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_40pjsq8cccl4rk2e5v25b0vra9